Stock analysts at Piper Jaffray Companies assumed coverage on shares of Motus GI (NASDAQ:MOTS) in a research note issued on Sunday, The Fly reports. The firm set an “overweight” rating on the stock.

Shares of Motus GI (MOTS) traded up $0.04 during trading on Friday, reaching $4.98. 27,335 shares of the company’s stock were exchanged, compared to its average volume of 96,522. Motus GI has a 1-year low of $3.75 and a 1-year high of $5.28.

In other Motus GI news, major shareholder Life Sciences Maste Perceptive purchased 1,000,000 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were bought at an average price of $5.00 per share, with a total value of $5,000,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gary J. Pruden purchased 50,000 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were acquired at an average cost of $5.00 per share, for a total transaction of $250,000.00. The disclosure for this purchase can be found here. Insiders have bought a total of 1,175,000 shares of company stock worth $5,875,000 in the last ninety days.

ILLEGAL ACTIVITY WARNING: “Motus GI (MOTS) Coverage Initiated at Piper Jaffray Companies” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at

Motus GI Company Profile

Motus GI Holdings, Inc is a medical technology company. The Company is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure.

The Fly

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with's FREE daily email newsletter.